Clinical Trial Update: Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating two cycles of induction chemotherapy with Abraxane, Cetuximab, Cisplatin, and 5-FU in advanced head and neck squamous cell carcinoma ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• 5-FU (5-fluorouracil)
• Abraxane (paclitaxel albumin-bound)
• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2014-01-07